Intellia stock price today nyse

Author: qtyb

August undefined, 2024

Nettet33,485.29 +2.57(+0.01%) Nasdaq 12,087.96 +91.09(+0.76%) Russell 2000 1,754.46 +2.33(+0.13%) Crude Oil -0.24(-0.30%) Gold Microchip Technology Incorporated (MCHP) NasdaqGS - NasdaqGS Real Time... Nettet11. apr. 2024 · Based on short-term price targets offered by 22 analysts, the average price target for Intellia Therapeutics, Inc. comes to $94.18. The forecasts range from a low of $39.00 to a high of...

Top Wall Street analysts say buy stocks like AMD & Chegg - CNBC

Nettet14. mar. 2024 · Since Intellia is still a clinical-stage biotech, all of its revenue is earned from its collaboration agreements that are in place with Novartis (NYSE: NVS) and Regeneron Pharmaceuticals... NettetIntellia Therapeutics Inc (NTLA) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad. Not an offer or recommendation by … the balm stamina blush

Is It Too Late to Buy Intellia Therapeutics? The Motley Fool

NettetIntellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. NettetIntellia Therapeutics, Inc. (NTLA) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. 37.27 +1.25 (+3.47%) At close: 04:00PM EDT. 38.20 +0.93 (+2.49%) Nettet13. apr. 2024 · Citigroup upgraded Intellia Therapeutics from a "sell" rating to a "neutral" rating and dropped their price objective for the stock from $48.00 to $39.00 in a report on Tuesday, January 24th. Finally, Robert W. Baird lowered their price target on Intellia Therapeutics from $58.00 to $42.00 and set a "neutral" rating for the company in a … the greyhound at halton

Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote & News

Intellia Therapeutics, Inc. Common Stock (NTLA) - Nasdaq

Nettet11. apr. 2024 · Based on short-term price targets offered by 22 analysts, the average price target for Intellia Therapeutics, Inc. comes to $94.18. The forecasts range from a … Nettet6. apr. 2024 · Wall Street Analysts Believe Intellia Therapeutics, Inc. (NTLA) Could Rally 145.32%: Here's is How to Trade. The mean of analysts' price targets for Intellia … the balm stainiac sephoraNettetIntellia Therapeutics Inc (NTLA) Stock Price & News - Google Finance -0.68 Home NTLA • NASDAQ Intellia Therapeutics Inc Follow Share $35.96 After Hours: $36.19 (0.64%) … the balm store horaires

"NettetAccording to 2 Wall Street analyst s that have issued a 1 year DNA price target, the average DNA price target is $5.50, with the highest DNA stock price forecast at $6.00 and the lowest DNA stock price forecast at $5.00. On average, Wall Street analysts predict that Ginkgo Bioworks Holdings 's share price could reach $5.50 by Nov 29, … " - Intellia stock price today nyse

Intellia stock price today nyse

NTLA Intellia Therapeutics Inc. Stock Price & News - WSJ

NettetIs Intellia Therapeutics (NASDAQ:NTLA) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Last updated Friday March 24th 8:15pm NettetTwist Bioscience Corporation (TWST) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 2 minutes Twist Bioscience Corporation (TWST) NasdaqGS - NasdaqGS Real...

Did you know?

Nettet10. apr. 2024 · Intellia Therapeutics (NASDAQ: NTLA) $35.79 (-1.1%) -$0.39 Price as of April 5, 2024, 4:00 p.m. ET Overview News & Analysis Financial Health Valuation … Nettet10. apr. 2024 · Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.

NettetIntellia Therapeutics Inc (NTLA) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. NTLA Intellia Therapeutics Inc 10,227 Watch Buy $35.96 $0.17 (0.47%) Today $35.96 0.00 (0.00%) After Hours Market Cap $3.17B Volume (M) … Nettet17. mar. 2024 · 7:30 am ET. Intellia Therapeutics Awarded Innovation Passport in the United Kingdom for NTLA-2002, an Investigational Genome Editing Treatment for Hereditary Angioedema. Globe Newswire. January 06, 2024. 7:49 am ET. Intellia Therapeutics stock price target cut to $131 from $173 at Stifel Nicolaus.

NettetIntellia Therapeutics Inc. research and ... Stock Price Target. High: $168.00: Low: $39 ... Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE ... Nettet6. apr. 2024 · The 12-month stock price forecast is $97.19, which is an increase of 173.44% from the latest price. Price Target $97.19 ( 173.44% upside) Analyst Consensus: Buy Stock Forecasts News All Videos Press Releases Conversation Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global

Nettet27. des. 2024 · Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approach Key Executives Trending …

Nettet1. jul. 2024 · The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a stellar 70% rise in just two trading days, after the company ... the greyhound at rotherfield peppardNettet13. apr. 2024 · With Intellia Therapeutics stock trading at $40.55 per share, the total value of Intellia Therapeutics stock (market capitalization) is $3.57B. Intellia Therapeutics stock was originally listed at a price of $22.10 in May 6, 2016. If you had invested in Intellia Therapeutics stock at $22.10, your return over the last 6 years would have … the greyhound bagby menuNettetIntellia Therapeutics Inc (NTLA) Stock Price & News - Google Finance -0.68 Home NTLA • NASDAQ Intellia Therapeutics Inc Follow Share $35.96 After Hours: $36.19 (0.64%) +0.23 Closed: Apr 6,... the greyhound at higham derbyshireNettetShares of the gene-editing pioneer Intellia Therapeutics (NASDAQ: NTLA) rose by 17.5% through the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence. There are currently eight medications approved by the FDA to prevent and/or treat HAE attacks. the balm store locatorNettetView the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. NTLA Intellia Therapeutics Inc. … the balm storeNettet13. apr. 2024 · Intellia Therapeutics. stock was originally listed at a price of $22.10 in May 6, 2016. If you had invested in Intellia Therapeutics stock at $22.10, your return over … thebalm stainiac tinted hint of tintNettet10. jul. 2024 · Intellia Therapeutics. Market Cap. $3B. Today's Change. Current Price. $35.96. Price as of April 6, 2024, 10:00 a.m. ET. You’re reading a free article with opinions that may differ from The ... the greyhound baltonsborough